Search | IOVS | ARVO Journals

View

Showing 1 – 20 of 38

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract May 2005

Evaluation of Telemetric Measurements of Intraocular Pressure Using Acute Hydrostatic IOP Elevation in Non–Human Primates

A. Doelemeyer; E.A. Polska; L. Schmetterer; G.N. Lambrou

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):1258. doi:

ARVO Annual Meeting Abstract May 2005

Intraorbital Optic Nerve Crush Induces Retinal Ganglion Cell Loss: Transient Protection With the Neurotrophic Factors BDNF, NT–4 or CNTF

G. Parrilla–Reverter; P. Sobrado–Calvo; S. Mayor–Torroglosa; J.M. Bernal; M. Salinas; M.E. Aguilera; E. Latour; G.N. Lambrou; M.P. Villegas–Pérez; M. Vidal–Sanz

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):1282. doi:

ARVO Annual Meeting Abstract May 2005

Role of M1 and M4 Receptors in Development of Myopia: Study With Muscarinic Receptor Antagonists and Muscarinic Toxins

S. Diether; F. Schaeffel; C. Fritsch; A.U. Trendelenburg; R. Payor; G.N. Lambrou

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):1986. doi:

ARVO Annual Meeting Abstract May 2005

Ocular Axial Growth Control and Proteomics: Differential Protein Expression in an Experimental Animal Model

E.F. Bertrand; C. Fritsch; K. Schmid; P. Schmid; D. Müller; P. Schindler; H. Towbin; J. van Oostrum; G.N. Lambrou; H. Voshol

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):3331. doi:

ARVO Annual Meeting Abstract May 2005

Morphological and Functional Assessment of Early Changes in the Macular Region and the Optic Nerve Head of Ocular Hypertensive Non–Human Primates

E.A. Polska; A. Doelemeyer; J.J. Kremers; A. Unterhuber; L. Schmetterer; W. Drexler; G.N. Lambrou

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):3512. doi:

ARVO Annual Meeting Abstract May 2004

Transient cataract in rodents: an isolated phenomenon induced by ketamine–xylazine?

C. Chatenay–Rivauday; T. Bensaoula; H. Ryckelynck; C. Gérard; N. Vidotto; A. Ottlecz; G.N. Lambrou

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):354. doi:

ARVO Annual Meeting Abstract May 2004

Oral Administration of the Selective COX–2 Inhibitor, Lumiracoxib, Significantly Reduces Choroidal Neovascular Membrane (CNVM) Development in the Rat Laser–Trauma Model

T.L. Cornell; W.–Z. Hu; M.H. Criswell; A. Ottlecz; R.P. Danis; G.N. Lambrou; T.A. Ciulla

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):494. doi:

ARVO Annual Meeting Abstract May 2004

SUCCESSFUL TREATMENT OF KERATOCONJUNCTIVITIS SICCA (KCS) IN DOGS WITH PIMECROLIMUS EYE DROPS: A COMPARISON WITH CYCLOSPORIN A (CyA) OPHTHALMIC OINTMENT.

R. Ofri; I. Allgoewer; U. Graenitz; T.M. Pena; B.M. Spiess; G.N. Lambrou; E. Latour

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):69. doi:

ARVO Annual Meeting Abstract May 2004

Pathology of Natual Hypertension in the Florida Monkey Colony

W.W. Dawson; B.E. Cunningham; E.C. Ogle; G.M. Hope; O.E. Malakhova; R.L. Cannon; M.B. Sherwood; G.N. Lambrou

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):1120. doi:

ARVO Annual Meeting Abstract May 2004

Inhibitory effect of atropine on myopia development in the chick: mode of application and unilateral versus bilateral lens wear.

K.L. Schmid; D.R. Brinkworth; K.M. Wallace; R.E. Payor; C. Fritsch; G.N. Lambrou

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):1239. doi:

ARVO Annual Meeting Abstract May 2004

Hypoxia–Induced COX–2 and VEGF Gene Expression are Down–regulated by LY294002 and U0126 in Retinal Cells: Repression of HIF–1alpha and NF–B–DNA Binding

J.–G. Cui; W.J. Lukiw; A. Ottlecz; G.N. Lambrou; N.G. Bazan

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):707. doi:

ARVO Annual Meeting Abstract May 2004

TELEMETRY–BASED CONTINUOUS PRESSURE MONITORING AS A TOOL TO REVEAL DORZOLAMIDE–INDUCED INTRAOCULAR PRESSURE CHANGES IN OCULAR HYPERTENSIVE CYNOMOLGUS MONKEYS.

M. Neuner–Jehle; C. Cojean; I. Questel; E. Faure; G.N. Lambrou

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):2118. doi:

ARVO Annual Meeting Abstract May 2004

Time–Series Changes in the Naturally Hypertensive Monkey Eye

J.C. Dawson; W.W. Dawson; B.E. Cunningham; E.C. Ogle; M.B. Sherwood; G.N. Lambrou

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):2164. doi:

ARVO Annual Meeting Abstract May 2004

Early morphological changes in non–human primate eyes with laser–induced ocular hypertension assessed with ultrahigh–resolution Optical Coherence Tomography, Scanning Laser Polarimetry and Scanning Laser Tomography.

E.A. Polska; A. Doelemeyer; A. Unterhuber; L. Schmetterer; W. Drexler; G.N. Lambrou

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):2176. doi:

ARVO Annual Meeting Abstract May 2004

Correlation of in vivo ultrahigh–resolution Optical Coherence Tomography with histological sections in non–human primate eyes

A. Doelemeyer; E. Polska; P. Schmid; A. Unterhuber; H. Sattman; B. Hermann; G.N. Lambrou; W. Drexler

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):2202. doi:

ARVO Annual Meeting Abstract May 2004

Investigation of a potential cone–survival factor gene in retinal disease.

R.J. Patel; T. Leveillard; N. Waseem; G.N. Lambrou; J.A. Sahel; S.S. Bhattacharya

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):2446. doi:

ARVO Annual Meeting Abstract May 2004

RETSCOPE : A BIO–INFORMATIC ANALYSIS OF GENE EXPRESSION IN THE DEGENERATIVE RETINA OF THE rd1 MOUSE, A MODEL OF RETINITIS PIGMENTOSA

T.D. Leveillard; F. Chalmel; C. Lavedan; N. Wicker; A. Dolemeyer; S. Mohand–Saïd; G.N. Lambrou; J.A. Sahel; O. Poch

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):2493. doi:

ARVO Annual Meeting Abstract May 2004

Short–term changes in the multifocal ERG measured in macaque eyes with laser–induced ocular hypertension

J.J. Kremers; A. Doelemeyer; E.A. Polska; C. Lambert; C. Cojean; I. Questel; E. Faure; G.N. Lambrou

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):3289. doi:

ARVO Annual Meeting Abstract May 2004

Lumiracoxib inhibits retinal neovascularization in a rat model of oxygen–induced retinopathy

A. Ottlecz; S.X. Zhang; J.–X. Ma; G.N. Lambrou

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):4037. doi:

ARVO Annual Meeting Abstract May 2004

PKC412 Reduces Retinal Neovascularization Induced by Hypoxic Stimuli in Pup Mice

T. Caillaud; T. Amar; A. Ottlecz; M. Wong; G.N. Lambrou; P.–P. Elena

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):4062. doi:

1 2

Next 20 Results »

Advertisement